Polyclonal Rabbit anti‑Human NCBP1 / CBP80 Antibody (1‑80 aa, N‑terminal, IHC, WB) LS‑C382487
Polyclonal Rabbit anti‑Human NCBP1 / CBP80 Antibody (1‑80 aa, N‑terminal, IHC, WB) LS‑C382487
Antibody:
NCBP1 / CBP80 Rabbit anti-Human Polyclonal (1-80 aa, N-terminal) Antibody
Application:
IHC, WB, ELISA
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Overview
Antibody:
NCBP1 / CBP80 Rabbit anti-Human Polyclonal (1-80 aa, N-terminal) Antibody
Application:
IHC, WB, ELISA
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Specifications
Description
CBP80 antibody LS-C382487 is an unconjugated rabbit polyclonal antibody to CBP80 (NCBP1) (1-80 aa, N-terminal) from human. It is reactive with human, mouse and rat. Validated for ELISA, IHC and WB.
Target
Human NCBP1 / CBP80
Synonyms
NCBP1 | CBP80 | NCBP | NCBP 80 kDa subunit | Sto1
Reactivity
Human, Mouse, Rat
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human CBP80
Epitope
1-80 aa, N-terminal
Specificity
CBP80 Polyclonal Antibody detects endogenous levels of CBP80 protein.
Applications
- IHC (1:100 - 1:300)
- Western blot (1:500 - 1:2000)
- ELISA (1:20000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot, ELISA
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot, Immunoprecipitation
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/22/2024